Sezer, O. Et Al. 2017. Effects of single-agent bortezomib as post-transplant consolidation therapy on multiple myeloma-related bone disease: a randomized phase II study. BRITISH JOURNAL OF HAEMATOLOGY , vol.178, no.1 , 61-71.

Sezer, O., BEKSAÇ, M., Hajek, R., Sucak, G., Cagirgan, S., Linkesch, W., ... Akay, O. M.(2017). Effects of single-agent bortezomib as post-transplant consolidation therapy on multiple myeloma-related bone disease: a randomized phase II study. BRITISH JOURNAL OF HAEMATOLOGY , vol.178, no.1, 61-71.

Sezer, Orhan Et Al. "Effects of single-agent bortezomib as post-transplant consolidation therapy on multiple myeloma-related bone disease: a randomized phase II study," BRITISH JOURNAL OF HAEMATOLOGY , vol.178, no.1, 61-71, 2017

Sezer, Orhan Et Al. "Effects of single-agent bortezomib as post-transplant consolidation therapy on multiple myeloma-related bone disease: a randomized phase II study." BRITISH JOURNAL OF HAEMATOLOGY , vol.178, no.1, pp.61-71, 2017

Sezer, O. Et Al. (2017) . "Effects of single-agent bortezomib as post-transplant consolidation therapy on multiple myeloma-related bone disease: a randomized phase II study." BRITISH JOURNAL OF HAEMATOLOGY , vol.178, no.1, pp.61-71.

@article{article, author={Orhan Sezer Et Al. }, title={Effects of single-agent bortezomib as post-transplant consolidation therapy on multiple myeloma-related bone disease: a randomized phase II study}, journal={BRITISH JOURNAL OF HAEMATOLOGY}, year=2017, pages={61-71} }